EULAR 2027 European Congress of Rheumatology
EULAR 2027, the European Congress of Rheumatology organised by the European Alliance of Associations for Rheumatology, takes place in Berlin, Germany, from 9 to 12 June 2027 and invites regular abstracts and case reports on clinical and basic research in rheumatic and musculoskeletal diseases. This guide covers topic areas consistent with the congress scope, readiness checks, what abstract reviewers typically value and practical steps for submitting before the 15 January 2027 abstract deadline.
The published deadline has passed. Check the official page in case it has been extended, or browse the open listings.
Key dates
- Abstract deadline
- 15 January 2027
- Full paper deadline
- Abstracts only, or not stated
- Conference dates
- 9 June 2027 – 12 June 2027
- Details last checked
- 10 November 2026
About the conference
- Conference
- EULAR 2027 European Congress of Rheumatology
- Organiser
- European Alliance of Associations for Rheumatology (EULAR)
- Venue
- Berlin, Germany
- Scope
- Annual European congress for clinical and basic research on rheumatic and musculoskeletal diseases, with regular abstracts and case reports invited.
- Submission types
- Abstracts; confirm formats and word limits on the official page
- Website
- Official conference website
Topics consistent with the programme
- Clinical studies of inflammatory arthritis, including rheumatoid and psoriatic arthritis
- Research on systemic autoimmune diseases such as lupus and systemic sclerosis
- Basic and translational studies of immune mechanisms in musculoskeletal disease
- Osteoarthritis, osteoporosis and other degenerative or metabolic bone conditions
- Epidemiology, outcomes and health services research in rheumatology
- Case reports describing unusual presentations or treatment responses
Based on the published scope; the official page sets out the full themes and requirements.
Is your work a fit? Check before you submit
- Confirm that the work concerns rheumatic or musculoskeletal diseases, in clinical or basic research.
- Decide whether the submission is a regular abstract or a case report and follow the matching format.
- Ensure the results are available and summarised with clear methods and conclusions.
- Check the abstract category, word limit and disclosure rules on the official abstract information page.
- Prepare a complete, co-author-approved abstract before 15 January 2027.
Why This Conference Matters
Rheumatic and musculoskeletal diseases affect people across the life course and involve clinicians, laboratory scientists, allied health professionals and patient organisations. The EULAR congress brings these groups together each year, so presenting there places new findings in front of the European and international rheumatology community at once. For early-career researchers, an accepted abstract offers visibility, feedback from experienced colleagues and a route to collaboration, while for established groups it is an opportunity to share emerging clinical and mechanistic results ahead of full publication.
Who Should Submit
Academic backgrounds
- Rheumatology
- Immunology
- Musculoskeletal and bone research
- Clinical epidemiology
- Physiotherapy and allied health
Institutions and sectors
- University hospitals and rheumatology departments
- Academic research institutes
- Pharmaceutical and biotechnology companies
- Patient and health professional associations
What Reviewers Typically Value
- Clinical findings that could inform diagnosis, monitoring or treatment decisions in rheumatology.
- Mechanistic studies that clarify disease pathways and point to potential therapeutic targets.
- Well-characterised cohorts or registries that report outcomes with appropriate statistical analysis.
- Case reports that describe a genuinely unusual presentation and draw a clear clinical lesson.
Ideas You Could Develop
Your Plan to the Deadline
A suggested schedule working back from 15 January 2027. Adjust it to the stage your work has reached.
By 4 Dec 2026
Open the official call for abstracts; confirm the tracks, word limit, format and author rules.
By 18 Dec 2026
Agree the key result, the authors and the presenting author.
By 1 Jan 2027
Draft the structured abstract to the word limit, with results stated as numbers.
By 8 Jan 2027
Circulate to co-authors and an independent reader; revise.
By 13 Jan 2027
Final checks: title, author affiliations, conflicts of interest and track selection.
By 15 Jan 2027
Submit through the official abstract system before the deadline.
What you gain
- Feedback from peers working on the same questions.
- A citable abstract or proceedings paper.
- Contacts for collaboration, employment and future funding.
- A step towards a full journal article.
What happens after you submit
- Acknowledgement: the abstract system confirms receipt; keep the submission number.
- Review: the scientific committee scores abstracts against the track criteria.
- Decision: accepted abstracts are assigned to an oral, poster or e-poster session.
- Registration: presenting authors usually must register by a stated date.
- Publication: accepted abstracts or papers may appear in the conference proceedings or journal supplement.
What the Organisers Are Looking For
The congress seeks clinical and basic research on rheumatic and musculoskeletal diseases, presented as regular abstracts or case reports. Strong submissions typically state a clear question, report results rather than plans, and explain the relevance for patients or for understanding disease. Categories, formatting rules and presentation formats should be confirmed on the official EULAR abstract information page before submission.
Expert help
How Pubrica Can Help
Pubrica’s subject specialists can help you prepare the abstract, full paper, poster or slides, planned back from the deadline. You remain the author of your work.
FAQs
Questions Researchers Ask
The next published deadline is 15 January 2027. Dates can change, so confirm them on the official page before you plan your work.
The congress scope indicates that case reports are invited alongside regular abstracts, so a well-documented case may be suitable. Specific requirements for case reports may differ from those for research abstracts, so check the EULAR abstract information page before submitting.
The official page lists abstract submission; check it for any full paper or proceedings option.
Yes. Pubrica’s specialists can review, write, edit and format your abstract, paper, poster or slides. You remain the author and the person responsible for the submission.
Sources
- European Alliance of Associations for Rheumatology (EULAR). (2026). EULAR 2027 European Congress of Rheumatology. Retrieved 10 November 2026, from https://congress.eular.org/abstractgeneralinfo
How to cite this page
Pubrica Insights. (2026). EULAR 2027 European Congress of Rheumatology. Pubrica. https://pubrica.com/insights/calls-and-conferences/eular-2027-european-congress-of-rheumatology/
Pubrica Insights. “EULAR 2027 European Congress of Rheumatology.” Pubrica, 2026, https://pubrica.com/insights/calls-and-conferences/eular-2027-european-congress-of-rheumatology/.
Pubrica Insights (2026) EULAR 2027 European Congress of Rheumatology. Pubrica. Available at: https://pubrica.com/insights/calls-and-conferences/eular-2027-european-congress-of-rheumatology/ (Accessed: 10 November 2026).
Pubrica Insights. EULAR 2027 European Congress of Rheumatology [Internet]. Pubrica; 2026 [cited 2026 Nov 10]. Available from: https://pubrica.com/insights/calls-and-conferences/eular-2027-european-congress-of-rheumatology/
Conference